Controlled and Sustained Release Formulations
Start with the big picture
These formulations are designed to maintain therapeutic plasma levels, reduce dosing frequency, support adherence, limit peak–trough fluctuations, and minimize side effects. The lesson distinguishes controlled release from sustained release and considers the properties that may make a drug suitable for these systems. It surveys release mechanisms such as diffusion, dissolution, polymer erosion, osmotic pressure, and ion exchange, alongside architectures including matrix and reservoir devices, osmotic pumps, depots, and other delivery formats. Formulation variables—including polymer properties, drug–polymer ratio, particle size, and coating characteristics—can influence release. Mathematical models help describe release profiles, while in-vitro and in-vivo evaluation approaches assess system performance.
What you'll learn
- Distinguish controlled-release systems from sustained-release systems.
- Summarize the therapeutic goals and candidate-drug considerations for CR/SR formulations.
- Identify major release-controlling mechanisms and dosage-form architectures.
- Explain how formulation variables can influence drug release.
- Describe the role of release models and evaluation methods in formulation development.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.